GlassScriptPhysician profile
Samantha Venkatesh
NPI 1417417825
$1,086.13
in general payments reported to CMS, 2019-2025
6 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.74 · 2021: $146 · 2022: $41.71 · 2023: $245 · 2024: $187 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Education: $118 · Travel and Lodging: $9.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.75 |
| Education | $118.49 |
| Travel and Lodging | $9.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $326.86 | 2024-2025 | Poteligeo |
| Lilly USA, LLC | $217.35 | 2022-2024 | Taltz, Olumiant |
| Abbvie INC. | $168.62 | 2020-2025 | |
| Janssen Biotech, INC. | $165.55 | 2021-2025 | Tremfya |
| Janssen Scientific Affairs, LLC | $137.65 | 2024 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $70.10 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Venkatesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.